The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan

OBJECTIVES/HYPOTHESIS: Dupilumab, which blocks the shared receptor component for interleukin‐4 and interleukin‐13, reduced polyp size, sinus opacification, and symptom severity, and was well tolerated in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) in the SINUS‐52 study (NCT028984...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujieda, Shigeharu, Matsune, Shoji, Takeno, Sachio, Asako, Mikiya, Takeuchi, Makiko, Fujita, Hiroyuki, Takahashi, Yoshinori, Amin, Nikhil, Deniz, Yamo, Rowe, Paul, Mannent, Leda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Allergy, Rhinology, and Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247406/
https://www.ncbi.nlm.nih.gov/pubmed/33226139
http://dx.doi.org/10.1002/lary.29230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247406/
https://www.ncbi.nlm.nih.gov/pubmed/33226139
http://dx.doi.org/10.1002/lary.29230

Ejemplares similares